Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
03:08am, Monday, 11'th Aug 2025
LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for viola
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
09:12am, Saturday, 09'th Aug 2025
NEW YORK , Aug. 9, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, b
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options If you purchased or acquired
RXST NEWS: Did RxSight, Inc. Mislead Investors? Contact BFA Law by September 22 Class Action Deadline (NASDAQ:RXST)
07:36am, Saturday, 09'th Aug 2025
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Compa
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors – Contact Levi & Korsinsky
04:27pm, Friday, 08'th Aug 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
RxSight, Inc. (RXST) Q2 2025 Earnings Call Transcript
02:29pm, Friday, 08'th Aug 2025
RxSight, Inc. (NASDAQ:RXST ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Oliver Moravcevic - Vice President of Investor Relations Ronald M. Kurtz - Co-President, CE
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates
07:16pm, Thursday, 07'th Aug 2025
RxSight, Inc. (RXST) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to break-even earnings per share a year ago.
RxSight (RXST) Q2 Loss Beats Estimates
06:23pm, Thursday, 07'th Aug 2025
RxSight (RXST) Q2 Loss Beats Estimates
Investors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights – RXST
04:36pm, Thursday, 07'th Aug 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).
RxSight, Inc. Reports Second Quarter 2025 Financial Results
04:05pm, Thursday, 07'th Aug 2025
ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followi
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on be
RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RXST
08:45am, Thursday, 07'th Aug 2025
NEW YORK , Aug. 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the class perio
